## NDSN: Nordson Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.1% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($227.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. NORDSON CORP SEC 10-K Report**
- Source: TradingView — Track All Markets | 20251217T214733 | Bullish | Relevance: 100%
- Nordson Corporation has released its 2025 Form 10-K report, highlighting significant financial growth, strategic initiatives, and operational success. The company reported robust financial performance with increased sales, operating profit, net income, and diluted EPS, driven by its Advanced Technology Solutions segment and strategic acquisitions. Nordson also outlined its Ascend strategy for long-term growth and discussed various challenges and risks, including economic conditions, trade policy, and supply chain disruptions.

**2. Nordson Q3 2025 Earnings: Record Margin Expansion Offsets Flat Revenue - News and Statistics**
- Source: IndexBox | 20251217T090805 | Somewhat-Bullish | Relevance: 100%
- Nordson reported flat sales in Q3 2025 year-over-year but achieved a record EBITDA margin of 34% due to strong operational execution and portfolio optimization, including a divestiture. CEO Sundaram Nagarajan highlighted broad-based demand in medical products and stable aftermarket parts, which helped offset declines in polymer processing and x-ray systems. Despite revenue missing analyst estimates, adjusted EPS and EBITDA beat expectations, and the company provided guidance for Q4 2025 and the upcoming financial year 2026.

**3. Taking Stock of Nordson (NDSN) Valuation After Strong Q4 Beat and Upgraded 2026 Guidance**
- Source: Simply Wall Street | 20251217T082841 | Bullish | Relevance: 100%
- Nordson (NDSN) exceeded Q4 expectations for fiscal 2025 and provided optimistic 2026 guidance, reinforcing a "mid teens" year-to-date share price return. Despite trading at a premium compared to the US Machinery group, a narrative-based fair value suggests the stock is 10.5% undervalued, driven by strategic shifts towards recurring revenue and portfolio optimization. Investors are encouraged to explore a detailed analysis for a comprehensive understanding of its valuation and risks.

**4. Is Nordson Stock Underperforming the S&P 500?**
- Source: Markets Financial Content | 20251215T062700 | Bullish | Relevance: 100%
- Nordson Corporation (NDSN), a large-cap company in the specialty industrial machinery industry, has shown mixed stock performance. While it has outperformed the S&P 500 over the past three months with a 5.5% gain, it has underperformed over six months and the past 52 weeks. Analysts maintain a "Moderate Buy" rating for NDSN, with a target price suggesting a potential 13.4% upside.

**5. Nordson (NASDAQ:NDSN) Upgraded by Vertical Research to "Buy" Rating**
- Source: MarketBeat | 20251215T145535 | Bullish | Relevance: 100%
- Vertical Research has upgraded Nordson (NASDAQ:NDSN) to a "Buy" rating from "Hold," setting a price target of $270.00, indicating a potential upside of 13.35%. This comes as Nordson reported stronger-than-expected quarterly EPS of $3.03 and provided an optimistic FY2026 EPS guidance of $10.80–$11.50, despite recent insider share sales totaling approximately $3.19 million. The company currently holds a consensus "Moderate Buy" rating among analysts with an average target price of $268.00.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | DA Davidson | $290 | $285 | +2% |
| 2025-12-12 | Baird | $275 | $252 | +9% |
| 2025-12-11 | DA Davidson | $285 | $285 | 0% |
| 2025-12-11 | Keybanc | $295 | $250 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | DA Davidson | main | Buy |
| 2025-12-12 | Baird | main | Neutral |
| 2025-12-11 | DA Davidson | main | Buy |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($1.77M) |
| Sells | 12 ($3.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 6.8% (-0.3%)
- State Street Corpora: 5.1% (-3.2%)
- Kayne Anderson Rudni: 4.4% (-2.4%)
- Geode Capital Manage: 2.7% (+1.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +5.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 19.8x stretched relative to 8% growth. Quality metrics strong (margin 17%). Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.5B |
| Beta | 1.02 |
| 52W Range | $165.03 - $251.47 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 19.8 |
| Current P/E | 21.3 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.9% to 3.1% (+5.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.9pp (needs >4.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.11% (CS: 59) | Neutral |
| RSI_14 | 56.3 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.017x | Above |
| vs SMA200 | 1.101x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $238.07
- **Stop Loss:** $227.29 (4.5% risk)
- **Target:** $248.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 100
- **Position Value:** $23,807.00
- **Portfolio %:** 23.81%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.93 | $3.03 | +3.4% |
| 2025Q3 | $2.64 | $2.73 | +3.5% |
| 2025Q2 | $2.36 | $2.42 | +2.6% |
| 2025Q1 | $2.08 | $2.06 | -0.9% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*